-
Swedish Orphan Biovitrum AB is an
international biopharmaceutical company dedicated to
treatments in the
areas of haematology,
immunology and specialty...
-
remnant of the Stockholm-based part of
Pharmacia was
partly spun off to
Biovitrum in 2001,
which sold off its
plasma products division to
Octapharma in...
- deficiency. The
applicant for this
medicinal product is
Swedish Orphan Biovitrum.
Altuvoct was
approved for
medical use in the
European Union in June 2024...
-
interleukin 1
receptor antagonist protein. It is
marketed by
Swedish Orphan Biovitrum.
Anakinra is
administered by
subcutaneous injection. It is used as a second...
-
Palifermin (trade name Kepivance,
marketed by
Biovitrum) is a
truncated human recombinant keratinocyte growth factor (KGF)
produced in
Escherichia coli...
- It was
developed by
Amgen and sold to Biovitrium, now
Swedish Orphan Biovitrum, in December, 2008. It is a 166
amino acid
protein produced by E. coli...
-
Orphan Biovitrum, in
December 2008)
Kineret (anakinra) for
rheumatoid arthritis,
exclusively licensed to Biovitrium, now
Swedish Orphan Biovitrum, in December...
- )
Sunovion (formerly Sepracor) (1984– )
Sutro (2003– )
Swedish Orphan Biovitrum (2001– )
Synthon (1991– )
Taisho (1912– )
Takeda (1781– ) Taro (1950–...
- 1993 Also
approved in
Canada and Australia.
Biogen and
Swedish Orphan Biovitrum (Sobi) are
collaborators in the
development and
commercialization of ALPROLIX...
- 1016/j.ymgme.2014.07.010. PMC 4533100. PMID 25066104.
Swedish Orphan Biovitrum AB,
Orfadin [package insert] (PDF),
retrieved 2016-07-12
Mieles LA, Esquivel...
